Citation

89 FR 2614

Canonical document for this Federal Register citation.

Request for Public Comment on NIOSH Initial Recommendations To Change the Status of Liraglutide and Pertuzumab on the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings Tuesday, January 16, 2024 89 FR 2614